PMID: 6160347Jan 1, 1981Paper

Adrenaline-induced hypertension in rats

Journal of Cardiovascular Pharmacology
H MajewskiM J Rand

Abstract

Rats were given a slow-release depot implantation containing adrenaline (0.33 mumole/kg). Adrenaline was released from the implant, giving a plasma level of 1.0 nmole/liter the day after implantation. Adrenaline-treated rats had elevated blood pressures compared to control rats from 1 day to 8 weeks after treatment. However, 8 weeks after treatment no adrenaline from the implant was found in the plasma, suggesting that at this time factors other than the adrenaline were responsible for maintaining the rise in blood pressure. In rats given metoprolol tartrate (5 mg/kg/day, p.o.), adrenaline treatment did not increase the blood pressure.

Citations

Jan 1, 1989·Clinical and Experimental Hypertension. Part A, Theory and Practice·R D GordonB Zeffane
Jan 1, 1989·European Journal of Applied Physiology and Occupational Physiology·F PéronnetJ de Champlain
Apr 1, 1986·Medicinal Research Reviews·Y Misu, T Kubo
Jan 1, 1985·Clinical and Experimental Hypertension. Part A, Theory and Practice·W P Anderson, D E Ramsey
Feb 21, 2016·British Journal of Pharmacology·A J M VerberneI J Llewellyn-Smith
Jan 1, 1989·Clinical and Experimental Hypertension. Part A, Theory and Practice·R D GordonB T Gueizelar
Oct 1, 1982·Naunyn-Schmiedeberg's Archives of Pharmacology·H MajewskiK Starke
Feb 1, 1991·Clinical and Experimental Pharmacology & Physiology·M EslerG Jennings
Jan 1, 1992·Hypertension·J S Floras
Jan 1, 1989·Clinical and Experimental Hypertension. Part A, Theory and Practice·P C ChangP van Brummelen
Jan 1, 1984·Clinical and Experimental Hypertension. Part A, Theory and Practice·W P Anderson, D T Harrison
Oct 12, 1999·The American Journal of Physiology·T NagayamaS Satoh
Jan 1, 1990·Annals of the New York Academy of Sciences·K R Borkowski
Jun 1, 1991·Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society·M EslerA Dart
Sep 1, 1981·Clinical and Experimental Pharmacology & Physiology·H MajewskiM J Rand
Jun 1, 1985·Journal of Autonomic Pharmacology·K R Borkowski, P Quinn
May 1, 1982·British Journal of Clinical Pharmacology·H H VincentM A Schalekamp
Oct 1, 1986·Medicinal Research Reviews·H Majewski, M J Rand
May 1, 1983·Clinical and Experimental Pharmacology & Physiology·M IrelandI Rouse
Jan 1, 1984·Clinical and Experimental Hypertension. Part A, Theory and Practice·M J Rand, H Majewski
Jun 1, 1988·Journal of Autonomic Pharmacology·K R Borkowski
Oct 12, 2018·The Journal of Physiology·E N Bardsley, D J Paterson
Apr 1, 1986·Clinical and Experimental Pharmacology & Physiology·H MajewskiM J Rand
Jan 1, 1986·Basic Research in Cardiology·P DominiakH Grobecker

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Arquivos brasileiros de cardiologia
José Albuquerque de Figueiredo NetoCésar Grupi
Zhonghua zhong liu za zhi [Chinese journal of oncology]
Cheng-feng WangYi-bin Xie
American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
Michael D KraftFrank Julian
© 2021 Meta ULC. All rights reserved